Trial
NCT01497626
Lapatinib and Bortezomib in Patients With Advanced Malignancies
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Georgetown University
Collaborators
GlaxoSmithKline; Millennium Pharmaceuticals, Inc.
Condition
Advanced Solid Tumors
Intervention
Lapatinib and bortezomib
Why stopped
Drug support withdrawn
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-02-17